Capstan Medical
Company developing heart valve implants and a catheter-based robotic delivery platform.
The record
- Vertical
- Devices & Robotics
- Headquarters
- Santa Cruz, California
- Founded
- 2020
What they do
Capstan Medical is based in Santa Cruz, California and was founded in 2020. It is developing heart valve implants and a catheter-based robotic delivery platform. Physicians steer the catheter and place the valve with a handheld controller. The Capstan Compass Robotic System is investigational and not approved for commercial use in the U.S. Maggie Nixon is CEO.
History and progression
How Capstan Medical got here, step by step.
March 2025
First-in-human procedures in Chile
First-in-human robotic-assisted mitral valve replacement procedures in Chile.
9 November 2026
First U.S. robot-assisted transcatheter mitral valve replacement
First U.S. robot-assisted transcatheter mitral valve replacement at The Christ Hospital in Cincinnati, led by Santiago Garcia, MD, in an FDA-authorized early feasibility study. Announced on November 16, 2026.
Key products
- Heart valve implants and Capstan Compass Robotic System
- Heart valve implants and a catheter-based robotic delivery platform under development. The system is investigational and not approved for commercial use in the U.S.
Recent news
16 November 2026
First U.S. investigational robotic mitral valve procedure
Your daily HealthTech Signal
No hype. Just signal.
Get the latest HealthTech news, understand why it matters, and see where the industry is headed.



Read by teams at companies like: